Albenza Side Effects
Generic Name: albendazole
Please note - some side effects for Albenza may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
Side Effects of Albenza - for the Consumer
Albenza
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Albenza:
Seek medical attention right away if any of these SEVERE side effects occur when using Albenza:Headache; nausea; stomach pain; vomiting.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); dark urine; decreased urination; fever, chills, or sore throat; red, swollen, peeling, or blistered skin; seizures; severe or persistent dizziness or headache; unusual bruising or bleeding; unusual tiredness or weakness; vision changes; yellowing of the eyes or skin.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
TopAlbenza Side Effects - for the Professional
Albenza
The adverse event profile of albendazole differs between hydatid disease and neurocysticercosis. Adverse events occurring with a frequency of ≥1% in either disease are described in the table below.
These symptoms were usually mild and resolved without treatment. Treatment discontinuations were predominantly due to leukopenia (0.7%) or hepatic abnormalities (3.8% in hydatid disease). The following incidence reflects events that were reported by investigators to be at least possibly or probably related to albendazole.
| Adverse Event | Hydatid Disease | Neurocysticercosis |
| Abnormal Liver Function Tests | 15.6 | <1.0 |
| Abdominal Pain | 6.0 | 0 |
| Nausea/Vomiting | 3.7 | 6.2 |
| Headache | 1.3 | 11.0 |
| Dizziness/Vertigo | 1.2 | <1.0 |
| Raised Intracranial Pressure | 0 | 1.5 |
| Meningeal Signs | 0 | 1.0 |
| Reversible Alopecia | 1.6 | <1.0 |
| Fever | 1.0 | 0 |
The following adverse events were observed at an incidence of <1%:
Blood and Lymphatic System Disorders
Leukopenia. There have been rare reports of granulocytopenia, pancytopenia, agranulocytosis, or thrombocytopenia. Patients with liver disease, including hepatic echinococcosis, appear to be more at risk of bone marrow suppression.
Immune System Disorders
Hypersensitivity reactions, including rash and urticaria.
Postmarketing Adverse Reactions
In addition to adverse events reported from clinical trials, the following events have been identified during world-wide post-approval use of Albenza. Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. These events have been chosen for inclusion due to a combination of their seriousness, frequency of reporting, or potential causal connection to Albenza.
Blood and Lymphatic System DisordersAplastic anemia, bone marrow suppression, neutropenia.
Hepatobiliary DisordersElevations of hepatic enzymes, hepatitis, acute liver failure.
Skin and Subcutaneous Tissue DisordersErythema multiforme, Stevens-Johnson syndrome.
Renal and Urinary DisordersAcute renal failure.
TopSide Effects by Body System - for Healthcare Professionals
General
The side effects of albendazole differ between hydatid disease and neurocysticercosis. The symptoms were generally mild and resolved without treatment. Treatment was discontinued primarily due to leukopenia (0.7%) or hepatic abnormalities (3.8% in hydatid disease).
Dermatologic
Dermatologic side effects have included reversible alopecia (1.6% in hydatid disease; less than 1% in neurocysticercosis). Erythema multiforme and Stevens-Johnson syndrome have been reported during postmarketing experience.
Hypersensitivity
Hypersensitivity side effects have included hypersensitivity reactions (including rash and urticaria) in less than 1% of patients.
Renal
Renal side effects have included acute renal failure during postmarketing experience.
Hepatic
Hepatic side effects have included abnormal liver function tests (15.6% in hydatid disease; less than 1% in neurocysticercosis) and hepatotoxicity (greater than or equal to 1%). Hepatic abnormalities, acute liver failure, elevations of hepatic enzymes, and hepatitis have been reported during postmarketing experience.
Hematologic
Hematologic side effects have rarely included granulocytopenia, agranulocytosis, pancytopenia, and thrombocytopenia. Leukopenia has been reported in less than 1% of patients. Aplastic anemia, bone marrow suppression, and neutropenia have been reported during postmarketing experience.
Gastrointestinal
Gastrointestinal side effects have included abdominal pain (6% in hydatid disease), nausea/vomiting (3.7% in hydatid disease; 6.2% in neurocysticercosis).
Nervous system
Nervous system side effects have included headache (1.3% in hydatid disease; 11% in neurocysticercosis), dizziness/vertigo (1.2% in hydatid disease; less than 1% in neurocysticercosis), raised intracranial pressure (1.5% in neurocysticercosis), meningeal signs (1% in neurocysticercosis).
Other
Other side effects have included fever (1% in hydatid disease).
Ocular
Ocular side effects have included retinal damage.
TopMore Albenza resources
- Albenza Prescribing Information (FDA)
- Albenza Concise Consumer Information (Cerner Multum)
- Albenza Monograph (AHFS DI)
- Albenza MedFacts Consumer Leaflet (Wolters Kluwer)
- Albenza Advanced Consumer (Micromedex) - Includes Dosage Information
- Albendazole Professional Patient Advice (Wolters Kluwer)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
